Ken Ren

Publishing 2020

Is this you? Claim this profile
1
Article
404
Reads on Journament
22
Co-authors
1
Journal

This page collects the articles indexed under the name Ken Ren. Profiles are grouped by name, so it can include work by someone else who shares it until the author claims the profile and confirms which papers are theirs.

Publications 1

  1. Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
    the oncologist 2020 404 reads CASI Pharmaceuticals (United States)

Possible papers by Ken Ren 2

Published under a similar spelling of the name. Beside each paper is the evidence that it may be the same person, strongest first; "Same name only" means there is nothing else to go on.

  1. Assessing the reliability, resilience and vulnerability of water supply system under multiple uncertain sources
    as K. Ren journal of cleaner production 2020 Xi'an University of Technology
    Same name only
  2. Mueller matrix-based calculating model for extracting polarization parameters in the analysis system for sea surface oil-spill
    as K. Ren infrared physics and technology 2019 Nanjing University of Science and Technology
    Same name only

Under these spellings

Same person? Claim this profile, then add these papers one by one or combine a whole spelling.

Is this you?

Claim this profile to connect it to your account. You will be able to remove papers that are not yours, fold in other spellings of your name, and show your affiliation and photo here.

Also published as

Tick the other spellings that are you. Leave the rest.

An admin reviews every claim. Your account's name, email address and affiliation are shown to them too.

You need an account to claim. No password: we email you a sign-in link, and your claim is sent as soon as you are back.

Institutions on these papers

  • CASI Pharmaceuticals (United States) · US 1

From OpenAlex, for papers with a DOI.

Frequent co-authors

Publishes in